The effectiveness of monotherapy with PI3K/AKT/mTOR pathway inhibitors in ovarian cancer: A meta-analysis. van der Ploeg P, Uittenboogaard A, Thijs AMJ, Westgeest HM, et al. Gynecol Oncol 2021 Jul 10. pii: S0090-8258(21)00538.

Read + Share

Amedeo Smart

Independent Medical Education

van der Ploeg P, Uittenboogaard A, Thijs AMJ, Westgeest HM, et al. The effectiveness of monotherapy with PI3K/AKT/mTOR pathway inhibitors in ovarian cancer: A meta-analysis. Gynecol Oncol 2021 Jul 10. pii: S0090-8258(21)00538.
PMID: 34253390